BJDX bluejaydx.com: Prakiraan wutah bathi kanggo taun ngarep
The growth of Bluejay Diagnostics (BJDX) relies on FDA approval of rapid sepsis tests and the sale of consumables. The projected EPS trend for the company for the coming year visualizes market expectations, where the value of 0.00 represents the most recent figure. Robotic systems automate bedside blood analysis, while management cohesion ensures the precise execution of the technology commercialization plan.
Rincian metrik lan analitis perusahaan bluejaydx.com (BJDX)
- rega lan prakiraan konsensus rega:
- data kapitalisasi saham perusahaan:
- indikator kapitalisasi buku:
- informasi babagan utang lan solvabilitas:
Total Utang marang Modal Bluejay Diagnostics|BJDX - Kewajiban jangka dawa marang modal|Utang jangka cendhak marang ekuitas Bluejay Diagnostics, Inc.|BJDX - Tanggungan utang kumulatif perusahaan|Utang-utang marang kapitalisasi buku Bluejay Diagnostics|BJDX - Utang jangka dawa perusahaan|Kewajiban jangka cendhak perusahaan Bluejay Diagnostics|Indikator likuiditas cepet bluejaydx.com
- data bathi resik lan rasio valuasi:
BJDX - Bathi pungkasan|Proyeksi bathi mangsa ngarep Bluejay Diagnostics|BJDX - Pangali rega marang bathi|Pangali Forward P/E Bluejay Diagnostics|BJDX - Kapitalisasi marang bathi resik kanthi nimbang wutah|Pangali EV/EBITDA Bluejay Diagnostics|BJDX - Bathi operasional EBITDA|Bathi resik saben saham (EPS TTM) Bluejay Diagnostics|BJDX - Bathi resik saben saham sajroning taun lumaku|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan bluejaydx.com|BJDX - Wutah bathi saben saham ing taun iki|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Bluejay Diagnostics
Pambiji fundamental:Bluejay, BJDX
This indicator reflects the analysts' consensus forecast for the change in net earnings per share for the coming year, measuring the expected business profitability trend. By analyzing the one-year forward EPS growth rate, an investor assesses the scaling potential of Bluejay Diagnostics (BJDX), where the implementation of robotic point-of-care rapid tests should radically reduce operating expenses and accelerate expansion within the diagnostics market.
Pesaing utama
Prakiraan wutah bathi resik saben saham kanggo taun ngarep Agilent Tech|Quest Corp (DGX) - Prakiraan konsensus wutah bathi saben saham kanggo taun ngarep|Prakiraan wutah bathi kanggo taun ngarep ILMN|Prakiraan wutah bathi resik saben saham kanggo taun ngarep EXAS (exactsciences.com)|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Revvity RVTY|Bio-Rad Laboratories, Inc. - Prakiraan wutah bathi resik saben saham kanggo taun ngarep|NNNN: Prakiraan wutah bathi saben saham kanggo taun ngarep|SHC - Prakiraan wutah bathi kanggo taun ngarep|QDEL: Prakiraan wutah bathi kanggo taun ngarep|Prakiraan wutah bathi resik saben saham ing taun ngarep opko.com (OPK)|Prakiraan wutah bathi resik saben saham kanggo taun ngarep CareDx, Inc.|MRVI (Maravai LifeSciences Holdings) - Proyeksi tambahing bathi saben saham ing taun ngarep|Prakiraan wutah bathi kanggo taun ngarep FLGT|Prakiraan wutah bathi kanggo taun ngarep Standard BioTools Corp (LAB)|Cytek Biosciences, Inc. - Prakiraan wutah bathi saben saham kanggo taun ngarep|orasure.com (OSUR) - Prakiraan wutah bathi resik saben saham ing taun ngarep|XGN: Prakiraan wutah bathi saben saham kanggo taun ngarep|Dinamika bathi saben saham sing diarepake ing taun ngarep MDXH (MDxHealth S.A.)|LUCD: Prakiraan wutah bathi kanggo taun ngarep|Proyeksi kacepetan wutah bathi saben saham kanggo taun ngarep PRE|IMDX (Insight Molecular Diagnostics, Inc.) - Prakiraan wutah bathi kanggo taun ngarep|Trinity Biotech Corp (TRIB) - Prakiraan konsensus wutah bathi saben saham kanggo taun ngarep|Prakiraan wutah bathi kanggo taun ngarep PRPH|Prakiraan wutah bathi kanggo taun ngarep Ainos Inc (AIMD)|Prakiraan wutah bathi kanggo taun ngarep CODX (Co-Diagnostics Corp)|Prakiraan wutah bathi resik saben siji saham kanggo taun ngarep Heart Test Labs|BMRA - Prakiraan wutah bathi resik saben saham kanggo taun ngarep|CDIO (Cardio Diagnostics) - Proyeksi kacepetan wutah bathi saben saham kanggo taun ngarep|Onconetix (ONCO) - Prakiraan wutah bathi resik saben saham kanggo taun ngarep|Prakiraan wutah bathi resik saben saham ing taun ngarep Virax Biolabs Group Limited (VRAX)|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Vermillion|Accelerate Diagnostics Inc (AXDX) - Prakiraan konsensus wutah bathi saben saham kanggo taun ngarep|Prakiraan wutah bathi saben saham kanggo taun ngarep CNTG (Centogene NV)|Proyeksi tambahing bathi saben saham ing taun ngarep ENZ|Prakiraan wutah bathi kanggo taun ngarep FRES (Fresh2 Group)|Prakiraan konsensus wutah bathi saben saham kanggo taun ngarep Genetic Technologies Ltd (GENE)|23andMe Inc. - Prakiraan wutah bathi kanggo taun ngarep|Psychemedics Inc (PMD) - Prakiraan wutah bathi saben saham kanggo taun ngarep
